DNA technology, the clinical laboratory, and the future.

Area of Science:

• Molecular biology
• Genomics
• Proteomics

Background:

• The Ninth Annual William Beaumont Hospital DNA Symposium highlighted advancements in molecular biology.
• Clinical applications of these techniques are rapidly evolving.

Purpose of the Study:

• To review clinically useful molecular biological techniques and their applications.
• To assess the impact of recent symposium findings on clinical practice.

Main Methods:

• Review of 10 submitted manuscripts from the symposium.
• Comparison of major findings with existing literature.
• Synthesis of data on pharmacogenetics, aneuploidy detection, cancer diagnostics, apoptosis, platelet aggregation, long QT syndrome, mycobacteria detection, and DNA collection.

Main Results:

• Genomic and proteomic approaches have yielded successful clinical assays.
• Comparative genomic hybridization offers an efficient alternative to cytogenetics for aneuploidy detection.
• Characterization of mutations in hereditary cancers, long QT syndromes, and thromboembolism.
• Pharmacogenetic insights into platelet aggregation and estrogen interaction.
• Protein expression aids in colorectal cancer staging and apoptosis signaling.
• Nucleic acid amplification and simplified buccal DNA collection present cost-effective strategies.

Conclusions:

• The completion of the Human Genome Project draft will accelerate the development of molecular pathology assays.
• Increased use of database software for genomic and proteomic screening will enhance assay development efficiency.